Sanofi Said to Be in Advanced Talks to Acquire Actelion

Sanofi Said to Be in Advanced Talks to Acquire Actelion


Sanofi is in advanced talks to acquire Actelion Ltd., according to people with knowledge of the matter, in a deal for the Swiss drugmaker that could be announced as soon as next week. The companies are discussing a price of about $275 per Actelion share, the people said, asking not to be identified because the negotiations are private.



from Biotech News